Page last updated: 2024-08-22

angiotensin ii and Cytokine Release Syndrome

angiotensin ii has been researched along with Cytokine Release Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Batlle, D; Kaplan, N; Lavker, RM; Lu, K; Peng, H; Wang, J; Wysocki, J; Yang, W	1
Kaesemeyer, W; Suvorava, T	1
Balestrieri, A; Barcellona, D; Caocci, G; Castagnola, M; Cau, R; Coghe, F; Coni, P; D'Andrea, F; Faa, G; Fanni, D; Gerosa, C; La Nasa, G; Ledda, F; Marongiu, F; Orru, G; Piras, M; Ronchi, A; Saba, L; Suri, JS	1

Reviews

2 review(s) available for angiotensin ii and Cytokine Release Syndrome

Article	Year
Targeting the Vascular Endothelium in the Treatment of COVID-19. Journal of cardiovascular pharmacology, 2021, 01-01, Volume: 77, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Delivery Systems; Endothelium, Vascular; Humans	2021
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Atrial Fibrillation; Blood Coagulation; Capillary Permeability; Cardiomyopathies; COVID-19; Cytokine Release Syndrome; Cytokines; Endothelium, Vascular; Fibroblasts; Fibrosis; Humans; Liver Cirrhosis; Myocarditis; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Thrombosis; Virus Internalization	2020

Article

Year

Targeting the Vascular Endothelium in the Treatment of COVID-19.

Journal of cardiovascular pharmacology, 2021, 01-01, Volume: 77, Issue:1

Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Delivery Systems; Endothelium, Vascular; Humans

2021

Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.

European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:23

Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Atrial Fibrillation; Blood Coagulation; Capillary Permeability; Cardiomyopathies; COVID-19; Cytokine Release Syndrome; Cytokines; Endothelium, Vascular; Fibroblasts; Fibrosis; Humans; Liver Cirrhosis; Myocarditis; Receptors, Coronavirus; Renin-Angiotensin System; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Thrombosis; Virus Internalization

2020

Other Studies

1 other study(ies) available for angiotensin ii and Cytokine Release Syndrome

Article	Year
The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:8 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chemokines; Cornea; COVID-19; Cytokine Release Syndrome; Disease Models, Animal; Epithelial Cells; Humans; Interleukins; Mice; Mice, Inbred C57BL; Mice, Knockout; SARS-CoV-2; THP-1 Cells; Tumor Necrosis Factor-alpha	2020

Article

Year

The ACE2-deficient mouse: A model for a cytokine storm-driven inflammation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:8

Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cells, Cultured; Chemokines; Cornea; COVID-19; Cytokine Release Syndrome; Disease Models, Animal; Epithelial Cells; Humans; Interleukins; Mice; Mice, Inbred C57BL; Mice, Knockout; SARS-CoV-2; THP-1 Cells; Tumor Necrosis Factor-alpha

2020